The neurofibromatosis 2 (NF2) tumor suppressor gene product, merlin, belongs to the ezrin-radixin-moesin (ERM) subgroup of the Protein 4.1 family, which links cell surface glycoproteins to the actin cytoskeleton. Previous studies have suggested that phosphorylation of merlin, similar to other ERM proteins, may regulate its function. To determine whether merlin phosphorylation has functional consequences for merlin suppression of cell growth and motility, we generated doxycycline-regulatable RT4 schwannoma cell lines that inducibly express full-length merlin with mutations at two potential phosphorylation sites (amino-acid residues S518 and T576). Whereas a mutation at S518 that mimics constitutive phosphorylation (S518D) abrogates the ability of merlin to suppress cell growth and motility, the S518A merlin mutant, which mimics nonphosphorylated merlin, functions equivalently to wild-type merlin. Similar mutations involving T576, the analogous phosphorylation site in ERM proteins important for regulating their function, had no effect. In contrast to other functionally inactive missense merlin mutants, the regulated overexpression of S518D merlin resulted in dramatic changes in cell shape and the elaboration of filopodial extensions. These results provide the first direct demonstration that the S518D merlin mutation, which mimics merlin phosphorylation, impairs not only merlin growth and motility suppression but also leads to an acquisition of a novel phenotype previously ascribed to ERM proteins.
Introduction
Neurofibromatosis 2 (NF2) is an autosomal dominant inherited cancer predisposition syndrome, in which affected individuals are prone to the development of schwannomas, meningiomas and ependymomas (Baser et al., 2003) . The NF2 tumor suppressor gene was identified by positional cloning and found to encode a 595 amino-acid protein with significant sequence similarity to a family of proteins that links the actin cytoskeleton to cell surface glycoproteins (Rouleau et al., 1993; Trofatter et al., 1993) . This family of proteins, which includes ezrin, radixin and moesin, are termed ERM molecules and share three conserved structural subregions important for their function (Tsukita et al., 1994) . The amino terminal FERM domain mediates binding to cell surface glycoproteins, like CD44, while the carboxyl terminal domain binds actin. In addition, ERM proteins form both intramolecular and intermolecular associations mediated by amino (FERM domain) to carboxyl terminal binding (Gary and Bretscher, 1993; Bretscher et al., 1995; Martin et al., 1995) . In the closed conformation where FERM/C-term association occurs, ERM proteins are inactive and do not bind F-actin (Gary and , whereas in the open, active conformation, ERM proteins are capable of inducing long membrane surface extensions (Henry et al., 1995; Martin et al., 1995) .
Like other ERM proteins, the NF2 gene product, merlin (or schwannomin), can associate with CD44 using FERM domain amino-acid residues (Morrison et al., 2001 ), but associates with actin by virtue of amino-acid residues in the amino terminus of the protein . In contrast to ERM proteins, merlin does not harbor the conventional ERM actinbinding domain in its carboxyl terminus. Merlin also forms both intramolecular and intermolecular FERM/ carboxyl terminal associations (Gonzalez-Agosti et al., 1999; Gutmann et al., 1999) . Previous studies have shown that the ability of merlin to function as a negative growth regulator is dependent on its ability to form a productive head-to-tail intramolecular association (Sherman et al., 1997; Gutmann et al., 1998; Morrison et al., 2001) .
The regulation of ERM intra/intermolecular associations and function is mediated by ERM phosphorylation (Tsukita et al., 1997) . ERM localization to the apical membrane and association with CD44 is dictated by phosphorylation mediated by Rho activation (Chen et al., 1995; Hirao et al., 1996; Matsui et al., 1998; Shaw et al., 1998a; Matsui et al., 1999) . Rho activation induces the rapid phosphorylation of ERM proteins on a conserved threonine residue (T558, moesin; T564, radixin; T567, ezrin; T576, merlin) to promote the formation of microvillar structures (Oshiro et al., 1998; Shaw et al., 1998a) . While phosphorylation of radixin on T564 has no effect on actin binding, it results in the loss of radixin intramolecular complex formation. In this regard, T564 phosphorylation unfolds radixin, promotes binding to CD44, and results in an 'active' functional ERM protein.
Phosphorylation of merlin, on the other hand, would be predicted to result in an unfolded, 'inactive' molecule that cannot bind CD44. Previous studies have demonstrated that merlin is phosphorylated by Rac1 on serine residue 518 (Shaw et al., 1998b (Shaw et al., , 2001 Xiao et al., 2002) . Phosphorylated merlin was shown to be less able to form a productive intramolecular complex (Shaw et al., 2001) and exhibited reduced binding to CD44 (Morrison et al., 2001) . Moreover, using phospho-S518 merlin antibodies, phosphorylated merlin exhibited a different subcellular distribution than unphosphorylated or wildtype merlin, which may be relevant to its function as a negative growth regulator (Shaw et al., 2001; Kissil et al., 2002) .
To determine the functional significance of merlin phosphorylation to NF2 gene function, we generated merlin mutants at amino-acid residues T576 and S518 that mimic nonphosphorylated (T576A and S518A) and phosphorylated (T576D and S518D) merlin, and examined the ability of these mutants to suppress cell growth and impair cell motility. We demonstrate that the S518D, but not the T576D merlin mutant, impairs the ability of merlin to suppress cell growth and reduce cell motility. In addition, expression of the S518D mutant merlin resulted in dramatic changes in cell shape and induced filopodia extension, which was not seen with 'nonphosphorylated' merlin (S518A) or other inactive merlin missense mutant molecules, suggesting that phosphorylation at S518 serves as a critical regulator of merlin activity.
Results
Merlin phosphorylation at S518, but not T576, is important for regulating growth and motility Alignment of the mammalian and Drosophila sequences with those of human ERM proteins demonstrates that the threonine residue at position 558, analogous to position 576 in merlin, and important for moesin intramolecular complex regulation, is highly conserved. In contrast, the serine residue at position 518, implicated in Rac-induced merlin phosphorylation (Shaw et al., 2001) , is not conserved among ERM proteins (arginine) or Drosophila merlin (threonine) (Figure 1) . In an effort to directly determine the relevance of phosphorylation at either S518 or T576 amino-acid residues on merlin function, we generated mutations at both sites to create mutants that represent nonphosphorylated (S518A or T576A) or phosphorylated (S518D or T576D) forms in the context of the full-length merlin molecule. In this report, we refer to the S518D and T576D merlin mutants as 'phosphorylated' merlin mutants, while S518A and T576A are referred to as 'nonphosphorylated' merlin mutants. These mutant merlin molecules were then examined for their ability to mediate functions previously ascribed to wild-type merlin, including growth suppression and impairment of cell motility.
To provide tightly regulated systems for the study of these merlin phospho-mutants, we utilized a tetracycline regulatable system in RT4 rat schwannoma cells, which have nearly undetectable levels of endogenous merlin expression. This system has been previously used in our laboratory for the study of merlin function Morrison et al., 2001) . Briefly, at least four independently generated and tightly regulated RT4 rat schwannoma clones were isolated for each mutant. We selected two clones of each mutant for further study. As shown in Figures 2a and 3a , we observed maximum levels of merlin induction by 24 h of treatment with 1 mg/ml doxycycline.
Induction of T576A or T576D mutant merlin in these cells resulted in reduced colony formation in soft agar ( Figure 2b ) and reduced motility as measured by a Boyden chamber migration assay (Figure 2c ). These results are comparable to the results obtained with wildtype merlin, arguing that mutations which mimic merlin phosphorylation at this site do not impair the ability of merlin to regulate cell growth or motility. In contrast, induction of S518D mutant merlin had no effect on RT4 schwannoma growth or motility, whereas wild-type merlin and merlin containing the 'nonphosphorylated' S518A mutation were both able to reduce cell growth Figure 1 Amino-acid sequence alignment for human merlin (NF2), radixin, moesin and ezrin and Drosophila merlin (Nf2). Phosphorylatable amino-acid residues S518 and T576 of human merlin are shown above the alignment. Amino-acid residue T558 in moesin, analogous to T576 in human merlin, is highly conserved among these proteins and has been shown to be involved in regulating ERM intramolecular complex formation. Conversely, S518, implicated in Rac-dependant phosphorylation of merlin, is not conserved among ERM family members and motility (Figure 3b and c) . These results argue that mutations which mimic phosphorylation of merlin at amino-acid residue 518 impair merlin function in vitro. These results are consistent with the results of McClatchey and co-workers (Shaw et al., 2001) , who suggested that merlin phosphorylation site at aminoacid residue S518 may have functional consequences.
Regulated expression of the S518D merlin mutant results in filopodial extension
Previous studies have suggested that merlin phosphorylation at serine 518 results in an alteration of merlin subcellular localization (Kissil et al., 2002) . Since merlin function may be related to changes in subcellular localization, we explored the possibility that S518 merlin phosphorylation mutants exhibit different subcellular localizations relative to wild-type merlin. Previous studies on S518D merlin localization, performed using high levels of transgene overexpression after transient transfection, demonstrated a dramatic localization of S518D merlin to vesicular structures, in contrast to wildtype or S518A merlin, which exhibited the typical plasma membrane distribution (Kissil et al., 2002) . In our experiments, induction of both wild-type and S518A mutant merlin expression in RT4 cells using the regulated doxycycline system resulted in a punctate merlin distribution at the plasma membrane ( Figure 4a ). While we observed S518D mutant merlin expression at the plasma membrane, there was also increased perinuclear staining. These findings suggest that regulated expression of 'phosphorylated' merlin (S518D) retains membrane localization and that dramatic differences in subcellular localization are unlikely to explain the inability of the S518D merlin mutant to suppress cell growth or reduce cell motility.
While we did not observe striking changes in merlin subcellular localization, regulated expression of 'phosphorylated' S518D merlin resulted in dramatic changes in cellular morphology. Most striking was the formation of long filopodial processes. We observed merlin localization in these filopodial extensions ( Figure 4a and data not shown). This cellular phenotype was found in all RT4 cells upon the induction of S518D merlin expression with doxycycline, but was not seen in S518D merlin RT4 cell lines prior to doxycycline exposure ( Figure 4b ). Moreover, we detected two or more filopodial extensions in 33 of 50 S518D merlin-expressing RT4 cells counted. In contrast, we did not observe filopodial extension in either uninduced or induced S518A mutant or wild-type merlin RT4 cell lines ( Figure 5a ). While we have demonstrated that the overexpression of radixin or ezrin has no effect on RT4 (Martin et al., 1997; Gautreau et al., 2000) . As ERM protein function is regulated by phosphorylation and 'phosphorylated' ERM mutants demonstrate increased activity, we hypothesized that the inability of the S518D merlin mutant to function as a tumor suppressor might reflect its conversion to an 'active' ERM protein.
To determine whether the abnormal morphologic appearance of RT4 cells expressing the S518D merlin mutant reflected altered binding to cytoskeletal proteins, GST affinity chromatography was used to determine the ability of the S518 mutants to interact with known merlin interactors implicated in cytoskeleton-mediated processes (bII-spectrin and ezrin). Similar to wild-type and S518A mutant merlin, S518D mutant merlin was able to interact with both bII-spectrin and ezrin in vitro (Figure 5b) . Identical results were observed with wildtype, S518A, and S518D merlin molecules using immunoprecipitation in RT4 cells in vivo (data not shown).
Lastly, we explored the possibility that all merlin missense mutants, which are defective as negative growth regulators, behave like ERM proteins with respect to filopodial process extension. We had previously generated a series of inducible RT4 cell lines that express NF2 merlin missense mutant molecules found in patients with NF2. These include NF2 mutations at amino-acid residues 64 (L64P), 79 (K79E), 106 (E106G), 535 (L535P) and 538 (L538P). All of these mutant merlin molecules were shown to be defective as growth regulators and did not modulate actin cytoskeletonmediated processes . In contrast to the results observed with regulated expression of the defective S518D merlin mutant, regulated expression of these inactive merlin molecules did not result in the elaboration of long filopodial processes (Figure 6 ). Similar results were observed with the K79E missense mutant (data not shown). Collectively, these results suggest that phosphorylation of merlin on amino-acid #2 and #12 for S518A; and #3 and #10 for S518D) . Maximum levels of merlin expression were achieved after 24 h of treatment with 1 mg/ml doxycycline. Merlin was detected using C-18 polyclonal antibody by Western blot. Tubulin was included as an internal control for equal protein loading. (b) Expression of the S518A, but not the S518D, mutant merlin results in reduced RT4 cell growth in soft agar, as described in the Materials and methods section. A decrease in the number of colonies was observed in cells expressing S518A mutant merlin compared to uninduced controls. This effect on RT4 cell growth was similar to that observed with wild-type merlin (NF2.17 clone #8). ( þ ) and (À) denote addition or omission of doxycycline, respectively. The mean and standard deviation for each condition are shown. Asterisks denote statistical significance using Student's t-test (Po0.05). (c) Expression of the S518A, but not the S518D, mutant merlin results in reduced RT4 motility using a Boyden chamber assay, as described in the Materials and methods section. Cells expressing S518A merlin showed reduced motility compared to uninduced cells. This effect on RT4 cell motility was similar to that observed with wild-type merlin (NF2.17 clone #8). ( þ ) and (À) denote addition or omission of doxycycline, respectively. The mean and standard deviation for each condition are shown. Asterisks denote statistical significance using Student's t-test (Po0.05) residue S518 results in a change in merlin functional properties, rather than merely leading to merlin inactivation.
Discussion
Members of the ERM family regulate the structure and function of microvilli and membrane ruffles by providing a regulated linkage between transmembrane glycoproteins and the filamentous actin (F-actin) cytoskeleton. This regulated attachment of plasma membrane proteins to F-actin is essential for establishing and maintaining cell shape, regulating cell adhesion and motility and integrating signal transduction pathways from transmembrane proteins, like CD43, CD44, and intercellular adhesion molecules (ICAMs) Bretscher et al., 2002; Gautreau et al., 2002) . In this regard, ERM proteins function as molecular integrators at the plasma membrane (Bretscher et al., 2002) .
Phosphorylation represents one mechanism for regulating the function of ERM proteins by modulating the ability of these proteins to form FERM/C-term associations (Nakamura et al., 1995; Matsui et al., 1998; Oshiro et al., 1998; Pietromonaco et al., 1998; Tran Quang et al., 2000; Ng et al., 2001) . When phosphorylated at threonine 558 (moesin), 567 (ezrin) or 564 (radixin), ERM proteins assume an open conformation and can interact with F-actin. Mutations that substitute aspartic acid for threonine to mimic phosphorylation result in an ERM protein that is constitutively active (Oshiro et al., 1998; Gautreau et al., 2000) .
This mutational approach of substituting phosphorylatable residues to amino acids that mimic both constitutively phosphorylated or nonphosphorylated (a) After merlin induction, RT4 cells were fixed and stained for merlin by immunofluorescence microscopy, as described in the Materials and methods section. C-18 anti-merlin antibody staining is shown on the left. Actin staining was performed using BODIPYphalloidin (center). Induction of wild-type and phospho-mutant merlin results in localization to the plasma membrane (arrows). In the S518D merlin-expressing cells, perinuclear localization is also evident. Strikingly, the morphological appearance of S518D expressing RT4 cells was dramatically altered and was associated with the elaboration of long filopodial processes, which also display merlin staining. (b) S518D merlin expression resulted in the elaboration of long filopodial extensions. Phase photomicrographs demonstrate these processes only after S518D merlin expression ( þ doxycycline for 24 h), but not in the absence of doxycycline (À doxycycline). Photomicrographs were taken at a magnification of Â 100. Bars denote 100 mm No filopodial extensions were observed in the absence of doxycycline (À doxycycline) or after doxycycline induction of wild-type or S518A merlin expression. Merlin expression was induced following 1 mg/ml doxycycline treatment for 24 h. Photomicrographs were taken at a magnification of Â 200. Bars denote 100 mm. (b) Binding to two known merlin-interacting cytoskeletal proteins, ezrin and bII-spectrin, was assessed using GST-fusion protein affinity chromatography in vitro. Similar to wild-type and S518A, S518D mutant merlin was able to interact with both ezrin and bII-spectrin. The input merlin protein is shown for each interaction (total). 'G' stands for GST alone and 'FP' stands for the GST fusion protein (ezrin or bII-spectrin)
analogues has been previously used to study the function and phosphorylation-dependent regulation of other proteins (Jabbur and Zhang, 2002; Ackerley et al., 2003; Gopalbhai et al., 2003) . For example, mutations that mimic phosphorylation of the neurofilament heavy chain result in reduced neurofilament transport (Ackerley et al., 2003) . Similarly, aspartic acid substitution at the phosphorylated amino-acid residue S212 of mitogenactivated protein kinase-1 (MEK-1) abolishes enzymatic activity, whereas alanine substitution enhances MEK activity (Gopalbhai et al., 2003) . Lastly, mutations of the p53 phosphorylatable amino-acid residues T18 and S20 to aspartic acid results in reduced p53 binding to its inhibitory partner Mdm-2, and enhanced expression of p53 transactivation targets (Jabbur and Zhang, 2002) . Like ERM proteins, merlin is also phosphorylated on serine and threonine residues (Shaw et al., 1998a) . Loss of cell adhesion or serum starvation is associated with decreased merlin phosphorylation, while increased phosphorylation is observed upon the addition of serum. Similarly, under conditions where growth arrest is triggered by CD44 activation, merlin is hypophosphorylated (Morrison et al., 2001) . These results suggest that merlin function might also be regulated by phosphorylation.
The critical C-term phospho-threonine amino-acid residue (T576) found in ERM proteins is also conserved in merlin. We sought to determine whether the T576 amino-acid residue in merlin was important for regulating merlin function. Our results demonstrate that mutations that mimic either phosphorylated or nonphosphorylated merlin at amino-acid residue T576 have no effect on merlin function. Moreover, these phosphomutations do not disrupt FERM/C-term interactions and do not impair binding of merlin to known merlin binding proteins (Haipek CA and Gutmann DH, unpublished observations). These results are consistent with recent studies demonstrating that significant merlin phosphorylation does not involve T576 (Shaw et al., 2001) , and suggests that the modulation of merlin function by phosphorylation involves amino-acid residues other than those implicated in the regulation of ERM protein function.
Phospho-amino-acid analyses have demonstrated that merlin is more heavily phosphorylated on serine residues (Shaw et al., 1998b) . By mutating most of the phosphorylatable sites in the carboxyl terminus of merlin, it was demonstrated that merlin phosphorylation involves amino-acid residue S518 (Shaw et al., 2001; Xiao et al., 2002) . Previous studies have shown that the phosphorylation of merlin coincides with growth-permissive conditions. In this respect, we hypothesized that active merlin is hypophosphorylated, while inactive merlin is hyperphosphorylated ). We directly tested this hypothesis using the regulatable RT4 rat schwannoma cell system, and demonstrated that S518A merlin is capable of suppressing both cell growth and motility, similar to wild-type merlin. In contrast, the S518D 'phosphorylated' merlin mutant did not suppress either cell growth or motility. These observations represent the first direct demonstration that merlin phosphorylation at aminoacid residue 518 impairs the known functional properties of merlin.
Interestingly, we observed a dramatic effect of S518D merlin expression on RT4 cell morphology. Whereas regulated expression of wild-type or S518A merlin resulted in localization of merlin at the plasma membrane and minor changes in cell shape, the expression of S518D was associated with the formation of long filopodial processes. This cellular phenotype is similar to that seen in cells upon ezrin overexpression , suggesting that phosphorylation of merlin on amino-acid residue S518 might convert merlin to an 'active' ERM protein, which lacks merlin growth regulatory properties. The fact that we did not observe similar morphologic changes upon regulated expression of other inactive missense merlin mutants argues that this effect is specific to merlin phosphorylation and is not a consequence of rendering merlin nonfunctional as a growth suppressor.
The results described in this study along with those reported by others support a model in which phosphorylation of merlin on amino-acid residue S518 regulates merlin function. In this regard, unphosphorylated merlin likely represents the active, growth suppressor form of merlin, which is capable of efficiently binding to CD44 and other merlin-interacting proteins (Morrison et al., 2001) . Under cellular conditions that promote merlin phosphorylation, merlin is rendered inactive as a growth regulator. However, in contrast to previous models, the fact that phosphorylated S518D merlin, unlike other functionally inactive merlin mutants, can promote filopodial process extension, suggests that merlin phosphorylation confers additional functional properties. Since ERM proteins have been implicated in the regulation of apoptosis (Gautreau et al., 1999) , it is possible that merlin phosphorylation may facilitate cell growth or reduce apoptosis under specific cellular conditions. In support of this notion, preliminary studies from our laboratory have demonstrated that S518D merlin exhibits growth-regulatory properties in concert with wild-type merlin (Haipek CA and Gutmann DH, unpublished observations). Collectively, these findings raise the intriguing possibility that phosphorylation not only dictates whether merlin can function as a growth regulator but also regulates the conversion of merlin from a tumor suppressor to a protein with different functional properties. Studies are in progress to determine whether this gain of function can positively regulate cell growth in the context of appropriate cellular conditions.
Materials and methods

Antibodies, cDNA constructs and cell lines
The merlin-specific rabbit polyclonal antibody (C-18; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and tubulinspecific antibody (Sigma, St Louis, MO, USA) were used for Western blots and immunocytochemistry. The merlin cDNAs used in these experiments were of human origin. Both phosphorylation and missense mutants were generated by oligonucleotide-directed mutagenesis using sense oligonucleotides containing a single nucleotide substitution using the Promega Gene Editor Kit according to the instructions provided by the manufacturer (Promega Corporation, Madison, WI, USA). Each construct was sequenced to verify the desired mutation. Merlin-expressing RT4 cell lines were established by transfecting RT4 cells containing the rtTA transcriptional regulator (developed by Helen Morrison, Karlsruhe, Germany) and puromycin resistance (pBABE.PURO) with either wild-type or mutant NF2.17 cloned into pUHD10.3 and pcDNA3 to confer G418 resistance (Morrison et al., 2001) . Several independent clones were selected in 500 mg/ml G418 and 1 mg/ml puromycin. Positive clones were screened for merlin expression using the C-18 rabbit polyclonal antibody. At least four to five positive clones per merlin construct were analysed and two representative clones were used for the analysis. RT4 cell lines transfected with pUHD10.3 vector alone demonstrated no changes in soft-agar growth, cell motility and morphology upon the addition of doxycycline.
Western blotting
Inducible RT4 cells were grown in either the presence or absence of doxycycline for 3, 6 and 24 h, and the protein concentration determined by the BioRad method (BioRad Laboratories, Hercules, CA, USA). Electrophoresis was performed using 75 mg of each sample loaded on 12% SDS-PAGE gels. Proteins were transferred onto Immobilon membranes (Millipore, Bedford, MA, USA) for Western blotting with merlin (C-18, 1 : 1000) and tubulin (1 : 20 000) antibodies. Western blots were developed using horseradish peroxidase-conjugated secondary antibodies (1 : 20 000) and ECL chemiluminescence (Amersham Biosciences, Piscataway, NJ, USA).
Growth in soft agar and cell motility
Soft-agar growth assays were performed in quadruplicate either in the presence or absence of doxycycline. Briefly, 1000 RT4 cells were plated in 24-well plates with medium containing 0.3% Noble agar for 14-21 days, as previously described Morrison et al., 2001) . The number of colonies was determined by direct counting on an inverted microscope, and the mean and standard deviation were determined for each condition. Each experiment was repeated three times with identical results.
Cell motility was determined in Transwell chambers containing 8 mm membranes. Briefly, the bottom surface of the membrane was coated with Matrigel (Fisher Scientific, Houston, TX, USA) and 10 000 cells grown for 24 h either in the presence or absence of doxycycline were seeded on the outside of the chamber and allowed to attach for 1 h . Cells were gently washed and then the Transwells were inverted for 48 h at 371C to allow for migration. Cells were then fixed in cold methanol for 30 min prior to staining with a LeukoStat staining kit (Fisher Scientific) and counted visually. The number of migrating cells was counted in quadruplicate and the mean and standard deviation were determined for each condition. Each experiment was repeated three times with identical results.
GST affinity chromatography
GST fusion protein constructs were transformed into DE3 (BL21) competent cells, induced overnight in 0.4 mM IPTG at room temperature and collected on glutathione-agarose beads (Sigma) for the interaction experiments. Coomassie-stained gels were used to estimate the amount of GST fusion protein after glutathione bead affinity chromatography relative to bovine serum albumin (BSA) standards. GST-bII-spectrin and GST-ezrin were kindly provided by Dr Stefan Pulst (Cedars Sinai Medical Center, Los Angeles, CA, USA) and Dr Heinz Furthmayr (Stanford University, Stanford, CA, USA), respectively.
In vitro transcribed and translated full-length merlin (wildtype, S518A and S518D) were synthesized in the presence of 35 S-methionine using the TnT protocol (Promega Corporation), according to the instructions provided by the manufacturer. Prior to performing the interaction, an input (total) fraction of radiolabeled protein was saved. Radiolabeled merlin fragments were then incubated with equimolar amounts of GST-fusion proteins immobilized on glutathione agarose beads for 2 h at 41C. Agarose beads were washed four times in NET buffer (25 mM Tris, pH 7.5; 100 mM NaCl; 3 mM EDTA; 0.1% Triton X-100) and eluted in 2 Â Laemmli buffer. An equal fraction of input and eluted bound fraction was separated by SDS-PAGE and analysed by autoradiography.
Fluorescence immunocytochemistry
Inducible RT4 cells were grown in either the presence or absence of doxycycline for 24 h, fixed in 3.7% formaldehyde for 10 min at room temperature and permeabilized with 0.1%
